ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR was delisted on the 27th of May, 2025.
9 hedge funds and large institutions have $4.89M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
1% less capital invested
Capital invested by funds: $4.96M → $4.89M (-$68K)
3.14% less ownership
Funds ownership: 23.29% → 20.15% (-3.1%)
25% less funds holding
Funds holding: 12 → 9 (-3)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
BCWM LLC
Overland Park,
Kansas
|
+$334K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$245K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$15.9K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$12K |
| 5 |
Morgan Stanley
New York
|
+$2.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$888K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$257K |
| 3 |
LPL Financial
San Diego,
California
|
-$56.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$24K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BL
1
BCWM LLC
Overland Park,
Kansas
| $3.66M | +$334K | +14,537 | +11% |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $606K | +$245K | +10,632 | +74% |
|
|
3
LPL Financial
San Diego,
California
| $553K | -$56.6K | -2,461 | -10% |
|
|
BBPWM
4
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $19K | – | – | – |
|
|
GT
5
Glenmede Trust
Philadelphia,
Pennsylvania
| $17K | – | – | – |
|
|
6
Creative Planning
Overland Park,
Kansas
| $17K | +$15.9K | +689 | New |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| $15K | +$12K | +520 | +520% |
|
|
8
Morgan Stanley
New York
| $2K | +$2.3K | +100 | New |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
10
Jane Street
New York
| – | -$888K | -41,822 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$257K | -12,144 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$24K | -1,141 | Closed |
|
|
SFS
13
Sowell Financial Services
North Little Rock,
Arkansas
| – | -$1K | -50 | Closed |
|
CNCR Hedge Fund Activity: Q1 2017 in Review
9 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) for Q1 2017, worth a combined $4.89M — down 1.4% from $4.96M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CNCR and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was BCWM LLC, adding an estimated $334K. The largest seller was Jane Street, exiting entirely with an estimated $888K sold.
- 9 institutional investors held ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) as of Q1 2017, down from 12 in Q4 2016.
- Funds reported $4.89M of ETF Series Solutions Trust Range Cancer Therapeutics ETF stock for Q1 2017, down 1.4% quarter-over-quarter.
- 2 funds opened new ETF Series Solutions Trust Range Cancer Therapeutics ETF positions in Q1 2017 and 4 closed out, a net change of -2 holders.
- The largest ETF Series Solutions Trust Range Cancer Therapeutics ETF buyer in Q1 2017 was BCWM LLC, an estimated $334K added.
- The largest ETF Series Solutions Trust Range Cancer Therapeutics ETF seller in Q1 2017 was Jane Street, an estimated $888K sold.
Based on aggregated 13F filings for Q1 2017.